期刊文献+

X染色体连锁的凋亡抑制蛋白对米非司酮诱导宫颈癌HeLa细胞凋亡的影响 被引量:1

The Influence of Mifepristone on Induction of Apoptosis and Effectiveness of XIAP in Uterine Cervix Cancer HeLa Cells
下载PDF
导出
摘要 目的观察X染色体连锁的凋亡抑制蛋白(XIAP蛋白)对米非司酮诱导宫颈癌HeLa细胞凋亡的影响。方法 XIAP重组质粒转染HeLa细胞,共聚焦显微镜观察其在细胞内的分布;流式细胞仪检测米非司酮处理和未处理的各组细胞凋亡率。结果 XIAP在HeLa细胞中弥漫分布于细胞核和细胞浆,米非司酮可诱导HeLa细胞凋亡,XIAP能抑制由米非司酮诱导的HeLa细胞凋亡。结论米非司酮能促进HeLa细胞凋亡,XIAP能抑制由米非司酮诱导的HeLa细胞凋亡。 Objective To investigate the effects of mifepristone-induced apoptosis in uterine cervix cancer cell line HeLa and the influence of mifepristone on the effectiveness of XIAP in uterine cervix cancer cells.Methods Human uterine cervix cancer cells lines HeLa were used for the current project.Expression,intracellular localization and function of the XIAP in HeLa cells were observed by Laser scanning confocal microscope after transfection.HeLa cells were induced by mifepristone.At the same time,the apoptosis were analyzed for different groups by FCM.Results Expression of DsRed2-XIAP fusion proteins in HeLa cells were observed in both nucleus and cytoplasm of HeLa cells.HeLa cells which were induced by mifepristone showed partly apoptosis.The DsRed2-XIAP fusion protein can inhibit apoptosis of HeLa cells by inducing of mifepristone.Conclusion The mifepristone can promote apoptosis of HeLa cells.The DsRed2-XIAP fusion protein can inhibit apoptosis of HeLa cells by inducing of mifepristone.
作者 汤飒爽
出处 《中国药业》 CAS 2011年第17期4-6,共3页 China Pharmaceuticals
关键词 细胞凋亡 宫颈癌 米非司酮 X染色体连锁的凋亡抑制蛋白 mifepristone uterine cervix cancer XIAP Apoptosis
  • 相关文献

参考文献9

  • 1Zong WX,Li C,Hatzivassiliou G,et al. Bax and Bak can localize to the endoplasmic reticulum to initiate apoptosis[J] .J Cell Biol, 2003, 162 (1):59-69.
  • 2Samuel T,Okada K,Hyer M,et al. clAP1 Localizes to the nuclear com- partment and modulates the cell cycle [ J]. Cancer Res, 2005,65:210 - 218.
  • 3Kuo PL,Hsu YL,Kuo YC,et al. The anti-proliferative inhibition of el- lipticine in human breast mda-rob-231 cancer cells is through cell cycle arrest and apoptosis induction[J]. Anticancer Drugs,2005,16(7): 789 - 795.
  • 4Nakshatri H, Rice SE, Bhat-Nakshatri P. Antitumor agent parthenolide reverses resistance of breast cancer ceils to tumor necrosis factor relat- ed apoptosis-inducing ligand through sustained activation of c-Jun N -terminal kinase[J]. Oncogene,2004,23 (44): 7 330 -7 344.
  • 5Suzuki Y,Nakabayashi Y,Nakatak et al. X-linked inhibitor of apopto- sis protein (XIAP) inhibits caspase-3 and caspase-7 in distinct modes[J]. J Biol Chem,2001,76(29): 27 058 -27 063.
  • 6Shiozaki EN, Chai J, Rigotti D J, et al. Mechanism of XIAP- Mediated Inhibition of caspase - 9[J ]. Mol Cell,2003,11 (2): 519 - 527.
  • 7Herr I debatin KM. cellular stress response and apoptosis in cancer therapy[J]. Blood,2001,98: 2 603 - 2 609.
  • 8Hang X, Lei L, Glas R, et al. Tumors acquire inhibitor of apoptosis pro- tein (IAP)- mediated apoptosis resistance through altered specificity of cytosolic proteolysis[J]. J Exp Med,2003,197:1 731 - 1 743.
  • 9王丹青.米非司酮在妇科肿瘤治疗中的应用[J].泸州医学院学报,2002,25(6):546-548. 被引量:3

二级参考文献21

  • 1Robbins A, Spitz IM. Mifepristone: Clinical pharmacology[J].Clinical Obstetrics and Gynecology, 1996;39: 436
  • 2Donaldson MS, Dorflinger L, Brown SS, eds. Clinical application of mifepristone RU486 and other antiprogestins[M].Washington DC:National Academy, 1993;1~277
  • 3Horwitz KB. The molecular biology of RU486. Is there a role for antiprogestins in the treatment of breast cancer?[J].Endocrine Rev, 1992;13:146
  • 4Sartorius CA, Groshong SD, Miller LA, et al. New T47D breast cancer cell lines for the independent study of progesterone B-and A-receptors: only antiprogestin-occupied B-receptors are switched to transcriptional agonist by cAMP[J]. Cancer Res, 1994;54:3868
  • 5Neulen J, Williams RF, Breckwoldt M, et al. Noncompetitive antioestrogenic actions of progesterone antagonists in primate endometrium: enhancement of estrogen and progesterone receptors with blockade of postreceptor proliferative mechanisms[J]. Hum Reprod, 1996;11:1533
  • 6Murphy AA, Morales AJ, Kettel LM, et al. Regression of uterine leiomyomata to the antiprogesterone RU486: does-response effect[J].Fertil. Steril, 1995;,64:187
  • 7Klijn JG, Setyono HB, Foekens JA. Progesterone antagonists and progesterone receptor modulators in the treatment of breast cancer[J].Steroids, 2000;65(10-11):825
  • 8Alban P, Hurd C, Dinda S, et al. Differential regulation of retinoblastoma protein by hormonal and antihormonal agents in T47D breast cancer cells[J].J-Steroid-Biochem-Mol-Biol, 2001;77(2-3):135
  • 9Lin VC, Aw SE, Ng EH, et al. Demonstration of mixed properties of RU486 in progesterone receptor (PR)-transfected MDA-MB-231 cells: a model for studying the functions of progesterone analogues[J]. Br-J-Cancer, 2001;85(12):1978
  • 10Hyder SM, Chiappetta C, Stancel GM. Pharmacological and endogenous progestins induce vascular endothelial growth factor expression in human breast cancer cells[J]. Int-J-Cancer, 2001;92(4):469

共引文献2

同被引文献11

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部